Derek N. Robertson, Ph.D.

Biochemistry Université de Montréal, Montréal, Canada 
Hypothalamic Development, GPCRs, Signalling Pathways, proteomics
"Derek Robertson"
Mean distance: 21373.2
Cross-listing: Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tudashki HB, Robertson DN, Schiller PW, et al. (2014) Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses. Molecular Pharmacology. 85: 148-61
Barclay Z, Dickson L, Robertson D, et al. (2013) Attenuated PLD1 association and signalling at the H452Y polymorphic form of the 5-HT(2A) receptor. Cellular Signalling. 25: 814-21
Barclay Z, Dickson L, Robertson DN, et al. (2011) 5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail. The Biochemical Journal. 436: 651-60
Johnson MS, Robertson DN, Holland PJ, et al. (2006) Role of the conserved NPxxY motif of the 5-HT2A receptor in determining selective interaction with isoforms of ADP-ribosylation factor (ARF). Cellular Signalling. 18: 1793-800
Robertson DN, Johnson MS, Moggach LO, et al. (2003) Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor. Molecular Pharmacology. 64: 1239-50
Mitchell R, Robertson DN, Holland PJ, et al. (2003) ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor. The Journal of Biological Chemistry. 278: 33818-30
Ronaldson E, Robertson DN, Johnson MS, et al. (2002) Specific interaction between the hop1 intracellular loop 3 domain of the human PAC(1) receptor and ARF. Regulatory Peptides. 109: 193-8
McCulloch DA, MacKenzie CJ, Johnson MS, et al. (2002) Additional signals from VPAC/PAC family receptors. Biochemical Society Transactions. 30: 441-6
McCulloch DA, Lutz EM, Johnson MS, et al. (2001) ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant. Molecular Pharmacology. 59: 1523-32
MacKenzie CJ, Lutz EM, Johnson MS, et al. (2001) Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor. Endocrinology. 142: 1209-17
See more...